Literature DB >> 8309268

Restrictive cardiomyopathy associated with the eosinophilia-myalgia syndrome.

P B Berger1, J Duffy, G S Reeder, B L Karon, W D Edwards.   

Abstract

OBJECTIVE: We report the first case of restrictive cardiomyopathy occurring in a patient with the eosinophilia-myalgia syndrome.
DESIGN: In this article, we discuss the various clinical manifestations of the eosinophilia-myalgia syndrome.
MATERIAL AND METHODS: In a 46-year-old woman with the eosinophilia-myalgia syndrome, orthopnea, chronic persistent edema, and severe dyspnea on exertion developed 2 years after she had discontinued use of L-tryptophan. Doppler echocardiography showed ventricular filling confined to early diastole and no atrial filling during ventricular systole--the Doppler hallmarks of restrictive disease. Right-sided cardiac catheterization revealed that the pulmonary wedge pressure equaled the pulmonary artery diastolic pressure and the mean right atrial pressure. A myocardial biopsy specimen showed dense endocardial fibrosis. Special immunofluorescent stains for eosinophilic granule major basic protein showed substantial deposition along the endocardial myocardial interface, an indication that eosinophils were present some time in the past.
RESULTS: A follow-up telephone call 14 months after the patient's initial assessment at the Mayo Clinic revealed that she had class III symptoms of congestive heart failure. She was receiving high doses of three diuretics daily, and her condition had improved considerably since her first examination at our institution.
CONCLUSION: Restrictive cardiomyopathy may occur in the setting of the eosinophilia-myalgia syndrome and should be considered in patients with this disease in whom exertional dyspnea and peripheral edema occur.

Entities:  

Mesh:

Year:  1994        PMID: 8309268     DOI: 10.1016/s0025-6196(12)61043-x

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  5 in total

1.  Churg-Strauss syndrome and myocardial perfusion SPECT imaging.

Authors:  Enrique Vallejo; Celso Mendoza-González; Alberto Aranda
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

Review 2.  Cardiac involvement with parasitic infections.

Authors:  Alicia Hidron; Nicholas Vogenthaler; José I Santos-Preciado; Alfonso J Rodriguez-Morales; Carlos Franco-Paredes; Anis Rassi
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 3.  Extracardiac medical and neuromuscular implications in restrictive cardiomyopathy.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

4.  Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

Review 5.  Cardiac manifestations of parasitic infections part 3: pericardial and miscellaneous cardiopulmonary manifestations.

Authors:  Carlos Franco-Paredes; Nadine Rouphael; José Méndez; Erik Folch; Alfonso J Rodríguez-Morales; José Ignacio Santos; J W Hurst
Journal:  Clin Cardiol       Date:  2007-06       Impact factor: 2.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.